A team of chemists, bioengineers and medical researchers based at the University of Pennsylvania and the University of Minnesota has lodged fluorescent materials called porphyrins within the surface of a polymersome, a cell-like vesicle, to image a tumour within a living rodent.
Their findings, which represent a proof of principle for the use of emissive polymersomes to target and visualise tumours, appear in the online edition of the Proceedings of the National Academy of Science (PNAS).
“We have shown that the dispersion of thousands of brightly emissive multi-porphyrin fluorophores within the polymersome membrane can be used to optically image tissue structures deep below the skin, with the potential to go even deeper,” said Michael J. Therien, a professor of chemistry at Penn. “It should also be possible to use an emissive polymersome vesicle to transport therapeutics directly to a tumour, enabling us to actually see if chemotherapy is really going to its intended target.”
This work takes advantage of years of effort in the Therien laboratory focused on the design of highly fluorescent compounds. Polymersomes, which were developed by Penn professors Daniel A. Hammer and Dennis Discher in the mid-1990s, function much like the bilayered membranes of living cells. Whereas cell membranes are created from a double layer of fatty phospholipid chains, a polymersome is comprised of two layers of synthetic co-polymers. Like a living cell, the polymersome membrane has a hydrophobic core. The study shows that the fluorophores evenly disperse within this core, giving rise to a nanometre-sized light-emitting structure.
“These polymers are also larger than phospholipids, so that there is enough space for the fluorophores, which are larger than the average molecule that is found inside cell membranes,” said Hammer, professor and chair of the Department of Bioengineering at Penn’s School of Engineering and Applied Sciences. “Another feature that makes emissive polymersomes so useful is that they self-assemble. Simply mixing together all component parts gives rise to these functional nanometre-sized, cell-like vesicles.”
In their study, the researchers demonstrate how they can use these emissive polymersomes to target markers on the surface of a specific type of tumour cells. When exposed to near-infrared light, which can travel through tissue, the fluorophores within the polymersome respond with a bright near-infrared signal that can then be detected.
“The fluorophores function like reflectors stuck in the spokes of a bicycle tire,” Therien said. “When this structure absorbs light, it gives rise to an intense, localised fluorescence signal that is uniquely suited for visualising living biological systems.”
According to Therein, there is keen interest in developing new technology that will enable optical imaging of cancer tissue, as such technology will be less costly and more accessible than MRI-based methods and free of the harmful side effects associated with radioactivity. In this imaging system, the flourophores can also be tuned to respond to different wavelengths of near-infrared light. This sets the stage for using emissive polymersomes to target multiple cancer cell-surface markers in the body simultaneously.
Emissive polymersomes perform much like in vivo imaging systems that use semiconductor-based “quantum dots.” These quantum dots, however, are hard matter, which could collect within the circulatory system, potentially causing a stroke. According to the Penn researchers, brightly emissive polymersomes define the first nanotech optical imaging platform based on non-aggregating “soft matter” (polymers and porphyrins) and hence have enormous potential in biomedicine.